A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus

Phase 2 Completed 140 enrolled Vertex Pharmaceuticals Incorporated

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the antiviral activity and safety of VX-787 given to healthy adult volunteers that have been inoculated with the influenza virus.

Timeline

Start: 2012-03
Primary completion: 2012-10
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pimodivir	Small molecule	—	Oral

A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus

Summary

Timeline

Drugs

Indications